Virus News and Research

Latest Virus News and Research

Study: CD4+ T cells could be important mediators of protection against Zika virus

Immune cells called CD4+ T cells could be important mediators of protection against the Zika virus, according to a study published January 24 in the open-access journal PLOS Pathogens by Sujan Shresta of the La Jolla Institute for Allergy and Immunology, and colleagues.

25 Jan 2019

Thousands of girls in the UK have not been vaccinated against HPV

The PHE campaign to vaccinate all girls between the ages of 12 and 18 years against HPV was only achieved in two-thirds of the population between 2017-2018.

25 Jan 2019

Investigational Ebola treatment found to be safe in adults

The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet.

25 Jan 2019

Newly developed algorithm could give pig farms advance notice of PEDV outbreaks

Researchers from North Carolina State University have developed an algorithm that could give pig farms advance notice of porcine epidemic diarrhea virus outbreaks.

25 Jan 2019

Standard method for ranking liver transplant waitlists may not prioritize the sickest candidates

A new study has uncovered that the standard method for ranking patients on the waitlist for lifesaving liver transplantation may not prioritize some of the sickest candidates for the top of the list.

25 Jan 2019

Ebola virus identified in a West African bat

The government of Liberia, in partnership with the Center for Infection and Immunity (CII) at the Columbia University Mailman School of Public Health and EcoHealth Alliance, announced the discovery of Ebola virus in a bat in Liberia.

24 Jan 2019

CMV vaccine provides a new way to fight malaria

Early research on a new approach to protecting against malaria is offering promising, potentially long-lasting results against the persistent parasite that sickens hundreds of millions people each year.

24 Jan 2019

Study reveals cost-effectiveness of needle and syringe programs in preventing HCV transmission

Providing clean injecting equipment through needle and syringe programmes is a highly cost-effective way of preventing hepatitis C transmission among people who inject drugs and could save millions of pounds in infection treatment costs in the UK, according to research led by the University of Bristol and London School of Hygiene & Tropical Medicine.

24 Jan 2019

FDA grants clearance to Hologic’s assay for detection of common sexually transmitted infections

Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for its Aptima Mycoplasma genitalium assay, the first and only FDA-cleared test to detect this under-recognized but increasingly common sexually transmitted infection (STI).

23 Jan 2019

Researchers use modified type of flu virus to develop new therapies for prostate cancer

Scientists from Queen Mary University of London have received a grant from leading men's health charity, Prostate Cancer UK, as London continues to lead the way in advanced prostate cancer research.

23 Jan 2019

Gene-edited chickens could prevent future flu pandemic

British researchers are genetically engineering flu-resistant chickens in an effort to prevent the next deadly human flu pandemic.

23 Jan 2019

Previous dengue virus infection associated with protection from symptomatic Zika

Previous infection with dengue virus may protect children from symptomatic Zika, according to a study published January 22 in the open-access journal PLOS Medicine by Eva Harris of the University of California, Berkeley, and colleagues.

23 Jan 2019

Study: Prior dengue immunity in children may be protective against symptomatic Zika

Children with a history of prior dengue virus infection had a significantly lower risk of being symptomatic when infected by Zika virus, according to a study in Nicaragua of more than 3,000 children aged 2 to 14 years.

23 Jan 2019

TGen identifies polio-like virus as potential cause of Acute Flaccid Myelitis outbreak

The Translational Genomics Research Institute, an affiliate of City of Hope, has identified a polio-like virus as a potential cause of an outbreak of a disease known as Acute Flaccid Myelitis (AFM), a crippling condition that causes muscle weakness and paralysis usually among children.

23 Jan 2019

Virus News and Research

Latest Virus News and Research

Study: CD4+ T cells could be important mediators of protection against Zika virus

Thousands of girls in the UK have not been vaccinated against HPV

Investigational Ebola treatment found to be safe in adults

Newly developed algorithm could give pig farms advance notice of PEDV outbreaks

Standard method for ranking liver transplant waitlists may not prioritize the sickest candidates

Ebola virus identified in a West African bat

CMV vaccine provides a new way to fight malaria

Study reveals cost-effectiveness of needle and syringe programs in preventing HCV transmission

FDA grants clearance to Hologic’s assay for detection of common sexually transmitted infections

Researchers use modified type of flu virus to develop new therapies for prostate cancer

Gene-edited chickens could prevent future flu pandemic

Previous dengue virus infection associated with protection from symptomatic Zika

Study: Prior dengue immunity in children may be protective against symptomatic Zika

TGen identifies polio-like virus as potential cause of Acute Flaccid Myelitis outbreak

Study: Prior dengue infection could protect children from symptomatic Zika

Human 'common cold' virus continues to spread in wild chimpanzees

UNIST researcher named as recipient of Merck’s 2018 Life Science Awards

Scientists develop new gene therapy that prevents axon destruction in mice

Study finds critically low HPV vaccination rates among younger adolescents in the U.S.

DZIF scientists reveal problems with available diagnostics for Zika and chikungunya virus

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Newsletters you may be interested in